| Literature DB >> 23637831 |
Kai Liu1, Anhui Xing, Ka Chen, Bin Wang, Rui Zhou, Shihui Chen, Hongxia Xu, Mantian Mi.
Abstract
BACKGROUND: The effect of fruit juice on serum cholesterol and blood pressure in humans has generated inconsistent results. We aimed to quantitatively evaluate the effect of fruit juice on serum cholesterol and blood pressure in adults.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23637831 PMCID: PMC3634794 DOI: 10.1371/journal.pone.0061420
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow diagram showing the number of citations retrieved by individual searches of articles included in the review.
Characteristics of 19 randomized controlled trials included in analysis.
| Study | No. of subjects | Country | Study design | Participants | Duration | Juice group (Total polyphenols) | Control group | Type of diet |
|
| 34 | Austrilia | Parallel | Healthy | 2 wk | 400 mg elderberry juice powder (400 mg/d) | Placebo | Usual diet |
|
| 12 | Israel | Crossover | Stage I hypertension | 5 wk | 500 ml sweetie fruit juice (444.5 mg/d) | Placebo (115 mg/d) | Usual diet |
|
| 39 | US | Parallel | Coronary heart disease | 3 mo | 240 ml pomegranate juice (NR) | Placebo | NR |
|
| 38 | Spain | Parallel | Hemodialysis | 14 d | 100 ml concentrated red grape juice (640 mg/d) | No intervention | Usual diet, avoid intake of fruit and vegetables |
|
| 23 | US | Parallel | Type 2 diabetes mellitus | 28 d | 150 ml muscadine grape juice (NR) | No intervention | Usual diet |
|
| 30 | Spain | Parallel | Chronic obstructive pulmonary disease | 5 wk | 400 ml pomeranate juice (2660 mg/d) | Placebo | Controlled diet, limit berries, pomegranates, chocolate, nuts and wine |
|
| 20 | Scotland | Parallel | Healthy | 2 wk | 750 ml cranberry juice (852 mg/d) | Placebo (6.72 mg/d) | Usual diet |
|
| 16 | Spain | Parallel | Hemodialysis | 2 wk | 100 ml concentrated red grape juice (640 mg/d) | No intervention | Usual diet, avoid intake of fruit and vegetables |
|
| 40 | Japan | Parallel | Borderline isolate hypertension | 8 wk | 418 ml grape juice (885 mg/d) | Placebo | Usual diet |
|
| 51 | US | Parallel | Overweight | 12 wk | 480 ml concord grape juice (933.6 mg/d) | Placebo | Usual diet, avoid intake of other juices |
|
| 27 | US | Parallel | Metabolic syndrome | 8 wk | 50 g freeze-dried strawberry juice (2160 mg/d) | Water | Usual diet, avoid intake of other berries |
|
| 48 | US | Parallel | Metabolic syndrome | 8 wk | 50 g freeze-dried blueberry juice (1624 mg/d) | Water | Usual diet, avoid intake of other berries, green tea, cocoa, and soy |
|
| 62 | Norway | Parallel | Cardiovascular disease risk | 4 wk | 330 ml bilberry (NR) | Water | Usual diet, avoid intake of other berries and berry products |
|
| 63 | US | Crossover | Stage I hypertension | 8 wk | 490 ml concord grape juice (965 mg/d) | Placebo | Usual diet, avoid intake of grape juice, wine, grape products, green or black tea, dark juices |
|
| 26 | Brazil | Parallel | Overweight | 3 mo | 500 ml concentrated orange juice (65.2 mg/d) | No intervention | Usual diet, aerobic training 3 times per week |
|
| 20 | US | Parallel | Obesity | 1 mo | 120 ml pomegranate juice (NR) | Placebo | Usual diet |
|
| 44 | US | Crossover | Coronary artery disease | 4 wk | 480 ml cranberry juice (835 mg/d) | Placebo | Usual diet, avoid intake of grape juice, wine, grape products, green or black tea, dark juices |
|
| 24 | France | Crossover | Overweight | 4 wk | 500 ml orange juice (341.9 mg/d) | Control drink | Usual diet, avoid intake of citrus-containing foods and limit tea, coffee, cocoa, wine, fruit juice ≤200 mL/d |
|
| 31 | US | Parallel | Metabolic syndrome | 8 wk | 240 ml low-energy cranberry juice (458 mg/d) | Placebo | Usual diet, avoid intake of berries, green tea, cocoa, and soy products |
The studies by Reshef (2005), Cerda (2006), Park (2009), Hollis (2010), Dohadwala (2010), Dohadwala (2011), and Basu (2011) used fruit juice with polyphenols as main nutrients, and the study by Murkovic (2004), Summer (2005), Castilla (2008), Bannni (2006), Duthie (2006), Castilla (2008), Basu (2010), Karlsen (2010), Aptekmann (2010), Gonzalez-Ortiz (2011), and Morand (2011) used fruit juice with multi-nutrients (polyphenols, vitamins, and sugar et al.); a usual diet was similar to a conventional diet.
NR, not reported.
Figure 2Meta-analysis of effects of fruit juice on total cholesterol (TC) concentrations.
The result was obtained from a fixed-effects model. Sizes of data markers indicate the weight of each study in this analysis. The basis of classification of TC is referred to the National Cholesterol Education Program guidelines, Adult Treatment Panel III. WMD, weighted mean difference.
Figure 6Meta-analysis of effects of fruit juice on systolic blood pressure (SBP).
The result was obtained from a fixed-effects model. Sizes of data markers indicate the weight of each study in this analysis. WMD, weighted mean difference.
Figure 3Meta-analysis of effects of fruit juice on high-density lipoprotein-cholesterol (HDL-C) concentrations.
The result was obtained from a fixed-effects model. Sizes of data markers indicate the weight of each study in this analysis. The basis of classification of HDL-C is referred to the National Cholesterol Education Program guidelines, Adult Treatment Panel III. WMD, weighted mean difference.
Figure 4Meta-analysis of effects of fruit juice on low-density lipoprotein-cholesterol (LDL-C) concentrations.
The result was obtained from a fixed-effects model. Sizes of data markers indicate the weight of each study in this analysis. The basis of classification of LDL-C is referred to the National Cholesterol Education Program guidelines, Adult Treatment Panel III. WMD, weighted mean difference.
Figure 5Meta-analysis of effects of fruit juice on diastolic blood pressure (DBP).
The result was obtained from a fixed-effects model. Sizes of data markers indicate the weight of each study in this analysis. WMD, weighted mean difference.
Subgroup analyses of TC, HDL-C, and LDL-C stratified by previously defined study characteristics.
| Study characteristics | Total cholesterol | HDL cholesterol | LDL cholesterol | |||||||||
| No. of trials | Net change(95% CI) | p for heterogeneity | p | No. of trials | Net change(95% CI) | p for heterogeneity | p | No. of trials | Net change(95% CI) | p for heterogeneity | p | |
|
| ||||||||||||
|
| 12 | −5.61 (−12.00, 0.78) | 0.76 | 0.08 | 11 | 0.87 (−0.77, 2.50) | 0.51 | 0.30 | 11 | −0.64 (−7.35, 6.07) | 0.52 | 0.85 |
|
| 7 | −3.92 (−9.26, 6.75) | 0.96 | 0.76 | 7 | −1.34 (−2.49, 1.83) | 0.91 | 0.76 | 7 | −2.57 (−7.03, 1.90) | 0.95 | 0.26 |
|
| ||||||||||||
|
| 15 | −4.33 (−9.98, 1.32) | 0.86 | 0.13 | 14 | 0.81 (−0.66, 2.28) | 0.69 | 0.28 | 14 | −1.50 (−5.76, 2.76) | 0.72 | 0.49 |
|
| 4 | −2.42 (−13.10, 8.25) | 0.81 | 0.66 | 4 | −0.97 (−3.79, 1.84) | 0.79 | 0.50 | 4 | −3.49 (−11.10, 4.12) | 0.78 | 0.37 |
|
| ||||||||||||
|
| 7 | −6.59 (−13.91, 0.72) | 0.89 | 0.08 | 6 | −0.45 (−2.15, 1.26) | 0.84 | 0.61 | 6 | −2.15 (−9.85, 5.56) | 0.77 | 0.59 |
|
| 6 | −1.36 (−10.98, 8.26) | 0.82 | 0.60 | 6 | 1.94 (−0.66, 4.53) | 0.97 | 0.14 | 6 | 1.32 (−1.64, 8.68) | 0.51 | 0.73 |
|
| 3 | 3.71 (−10.45, 17.87) | 0.32 | 0.61 | 3 | −0.21 (−4.44, 4.01) | 0.98 | 0.92 | 3 | −2.30 (−7.95, 3.35) | 0.40 | 0.43 |
|
| 2 | −6.49 (−21.78, 8.80) | 0.87 | 0.41 | 2 | 6.41 (−5.42, 18.25) | 0.09 | 0.29 | 2 | −11.0 (−26.84, 4.83) | 0.94 | 0.17 |
|
| ||||||||||||
|
| 11 | −6.01 (−12.47, 0.45) | 0.99 | 0.07 | 10 | −0.18 (−2.37, 2.01) | 0.92 | 0.87 | 10 | −2.31 (−6.92, 2.30) | 0.73 | 0.33 |
|
| 8 | −0.81 (−8.68, 7.06) | 0.32 | 0.84 | 8 | 0.99 (−0.92, 2.91) | 0.35 | 0.31 | 8 | −1.34 (−7.62, 4.93) | 0.81 | 0.68 |
|
| ||||||||||||
|
| 11 | −6.37 (−12.60, −0.14) | 0.99 | 0.045 | 10 | 0.76 (−1.27, 2.80) | 0.27 | 0.46 | 10 | −2.57 (−9.27, 4.13) | 0.69 | 0.45 |
|
| 5 | −1.73 (−11.95, 8.48) | 0.65 | 0.74 | 5 | 0.25 (−1.60, 2.10) | 0.94 | 0.79 | 5 | −2.71 (−7.48, 2.06) | 0.71 | 0.27 |
|
| ||||||||||||
|
| 12 | −6.08 (−12.97, 0.82) | 0.96 | 0.08 | 12 | 0.64 (−0.94, 2.23) | 0.39 | 0.43 | 12 | −0.60 (−6.69, 5.49) | 0.77 | 0.85 |
|
| 7 | −1.53 (−8.77, 5.71) | 0.94 | 0.68 | 6 | −0.04 (−3.00, 2.91) | 0.79 | 0.98 | 6 | −2.79 (−7.48, 1.90) | 0.65 | 0.24 |
|
| ||||||||||||
|
| 10 | −11.55 (−8.53, 5.43) | 0.72 | 0.66 | 10 | 0.14 (−1.36, 1.65) | 0.44 | 0.85 | 10 | −0.96 (−6.53, 4.61) | 0.81 | 0.74 |
|
| 6 | −6.49 (−14.97, 1.99) | 0.91 | 0.13 | 5 | 1.93 (−1.62, 5.49) | 0.90 | 0.29 | 5 | −2.80 (−8.23, 2.64) | 0.31 | 0.31 |
|
| 3 | −6.17 (−19.45, 7.12) | 0.63 | 0.36 | 3 | 0.54 (−3.33, 4.41) | 0.54 | 0.78 | 3 | −2.74 (−15.34, 9.86) | 0.72 | 0.67 |